1. Home
  2. RPAY vs EMBC Comparison

RPAY vs EMBC Comparison

Compare RPAY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repay Holdings Corporation

RPAY

Repay Holdings Corporation

HOLD

Current Price

$4.35

Market Cap

291.0M

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

SELL

Current Price

$6.73

Market Cap

328.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RPAY
EMBC
Founded
2006
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.0M
328.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
RPAY
EMBC
Price
$4.35
$6.73
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
★ $6.85
$4.00
AVG Volume (30 Days)
322.0K
★ 836.9K
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
N/A
★ 20.90
EPS
N/A
★ 1.03
Revenue
★ $309,261,000.00
N/A
Revenue This Year
$59.12
N/A
Revenue Next Year
$27.40
$5.59
P/E Ratio
★ N/A
$6.63
Revenue Growth
N/A
★ N/A
52 Week Low
$2.30
$2.77
52 Week High
$5.25
$14.91

Technical Indicators

Market Signals
Indicator
RPAY
EMBC
Relative Strength Index (RSI) 66.12 67.69
Support Level $3.51 $3.01
Resistance Level $4.55 $9.38
Average True Range (ATR) 0.15 0.28
MACD 0.04 0.05
Stochastic Oscillator 99.14 84.15

Price Performance

Historical Comparison
RPAY
EMBC

About RPAY Repay Holdings Corporation

Repay Holdings Corp is a payments technology company. It provides integrated payment processing solutions to industry-oriented vertical markets in which businesses or other organizations have specific transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments. The company generates majority of its revenue from Consumer Payments segment.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: